GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolap...(t is specifically designed to offer pati...)

Date:3/12/2009

t is specifically designed to offer patients even higher levels of comfort with improved biocompatibility to work with the body's natural healing process while correcting the prolapse," said Salil Khandwala, MD, Clinical Associate Professor, Wayne State University, Michigan.

Pelvic organ prolapse (POP) is characterized by the abnormal descent or herniation of pelvic organs. Forty percent of women aged 40 to 79 are affected by pelvic organ prolapse, a condition in which weak pelvic floor muscles cause the pelvic organs to fall out of place. By age 80, more than one out of every 10 women will have undergone surgery for prolapse or urinary incontinence. Pelvic organ prolapse can affect a woman's daily life, limiting physical activity and sexual intimacy. Each year approximately 200,000 inpatient procedures are performed in the US to correct POP.

All surgical procedures present some risks. Complications associated with surgical treatment for POP include injury to blood vessels of the pelvis, difficulty urinating, pain, scarring, pain with intercourse, bladder and bowel injury. There is also a risk of the mesh material becoming exposed into the vaginal canal. Mesh exposure can be associated with pain during intercourse for the patient and her partner. Exposure may require treatment, such as vaginal medication or removal of the exposed mesh.

GYNECARE PROLIFT+M(TM) was developed by Ethicon Women's Health & Urology.

About Ethicon Women's Health & Urology

Ethicon Women's Health & Urology offers treatment solutions for a range of common, female pelvic health disorders. The technologies are marketed under the GYNECARE family of brands and include treatments for menorrhagia (heavy periods), fibroids, stress urinary incontinence and pelvic organ prolapse. Ethicon Women's Health & Urology is a division of Ethicon, Inc, a Johnson & Johnson company. For more
'/>"/>

SOURCE Ethicon, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers
2. Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
3. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
4. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
5. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
6. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Repair Stem Cell Institute Announces Science Advisory Board
10. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
11. Real-time observation of the DNA-repair mechanism